Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2012
06/21/2012US20120156234 Means for treating synucleinopathies
06/21/2012US20120156233 Vaccine therapy for choroidal neovascularization
06/21/2012US20120156231 Foxm1 peptides and vaccines containing the same
06/21/2012US20120156230 Treatment of spinal cord injury and traumatic brain injury using placental stem cells
06/21/2012US20120156228 Methods, Kits, and Compositions for Generating New Hair Follicles and Growing Hair
06/21/2012US20120156223 Method for Inhibiting Scavenger Receptor-A and Increasing Immune Response to Antigens
06/21/2012US20120156222 Prevention and treatment of alzheimer's disease
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012US20120156215 Phage-GnRH Constructs, Their Mimics, Antigenic Compositions, and Sequences for Immunocontraception of Animals and Other Applications
06/21/2012US20120156214 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
06/21/2012US20120156213 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
06/21/2012US20120156211 Porphyromonas gingivalis polypeptides
06/21/2012US20120156207 Methods and compositions for inhibiting cd32b expressing cells
06/21/2012US20120156201 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
06/21/2012US20120156198 Antibodies against IL-18R1 and uses thereof
06/21/2012US20120156169 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156144 Foamable Compositions, Kits and Methods for Hyperhidrosis
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012CA2821893A1 Pyrazole derivative
06/21/2012CA2821492A1 Vaccine antigens that direct immunity to conserved epitopes
06/21/2012CA2821296A1 Cd89 activation in therapy
06/21/2012CA2820924A1 Method for suppressing an immune response
06/20/2012EP2465937A1 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid A (3D-MLA)
06/20/2012EP2465935A2 Recombinant human interferon-like proteins
06/20/2012EP2465928A1 Treatment of Th17-mediated diseases
06/20/2012EP2465538A2 Use of immunesuppressant receptor
06/20/2012EP2465536A1 CD89 activation in therapy
06/20/2012EP2465535A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/20/2012EP2465534A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/20/2012EP2465524A1 Autoantibody production inhibitor
06/20/2012EP2465508A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/20/2012EP2465507A1 Oligosaccharide composition for treating skin diseases
06/20/2012EP2465503A1 Pharmaceutical solution of cetirizine hydrochloride
06/20/2012EP2464667A2 N-acylated octasaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2464383A2 Compositions and methods for the therapy and diagnosis of influenza
06/20/2012EP2464377A1 Use of il-15 to increase thymic output and to treat lymphopenia
06/20/2012EP2464370A1 Modified vasoactive intestinal peptides
06/20/2012EP2464361A2 Composition having strains of lactobacillus fermentum
06/20/2012EP2464359A2 N-sulfated oligosaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2102169B1 Indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/20/2012EP2075258B1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same
06/20/2012EP2021321B1 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
06/20/2012EP2012773B1 Drugs and uses
06/20/2012EP1810979B1 STABILIZED HUMAN IgG4 ANTIBODIES
06/20/2012EP1691837B1 Ip-10 antibodies and their uses
06/20/2012EP1667971B1 Fexofenadine polymorphs and processes of preparing the same
06/20/2012EP1311267B1 A retroviral immunotherapy
06/20/2012CN1550236B Protein stability in aqueous solution
06/20/2012CN102510865A Nitrogen-containing spiro-ring compound and medicinal use of same
06/20/2012CN102504989A Male health wine
06/20/2012CN102504026A Full human single chain antibody capable of resisting epidermal growth-factor receptor and application thereof
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102504006A Steroid saponin compound in siberian fritillary bulb
06/20/2012CN102504001A 3, 5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof
06/20/2012CN102503959A Tricyclic compounds and preparation method thereof, and medicinal composition containing compounds and application thereof
06/20/2012CN102503932A Novel gas signal molecule donator and preparation method and use thereof
06/20/2012CN102503899A Crystal of phenylalanine derivative, process for producing the same and use thereof
06/20/2012CN102499969A Chinese medicinal preparation for treating allergic rhinitis
06/20/2012CN102499945A New application of bacterial endotoxin
06/20/2012CN102499931A New application of disaccharide compound
06/20/2012CN102499929A 42-(Dimethylphosphinate)rapamycin solid composition and coating method thereof
06/20/2012CN102499919A Medicine combination containing low sirolimus dose for treating or preventing fibrotic diseases
06/20/2012CN102499911A Tea saponine nanocapsule, preparation method and application thereof
06/20/2012CN102020623B Butterbur extract as well as preparation method and application thereof
06/20/2012CN101919875B Preparation method of enteromorpha mushroom polysaccharide compound
06/20/2012CN101849991B Magnolia biondii pamp volatile oil nanoliposome freeze-dried powder, temperature-sensitive magnolia biondii pamp nanogel and preparation method thereof
06/20/2012CN101829329B Tooth antiallergic composition
06/20/2012CN101781227B 2-N-[(1R, 2R)-1, 3-dihydroxy-1-phenylpropyl]-fatty amide compound, preparation and application thereof
06/20/2012CN101735329B Pholiota adiosapose polysaccharide and preparation method thereof
06/20/2012CN101596221B Process for preparing water-soluble ginkgo biloba extract used for injection
06/20/2012CN101474166B Cetirizine and pseudoephedrine sustained-release capsule and preparation method thereof
06/20/2012CN101461866B Method for preparing health-care medicinal liquor
06/20/2012CN101301462B Decoction for treating cold urticaria
06/20/2012CN101151248B 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
06/20/2012CN101052418B Use of bacterial endotoxin antibody in preparing medicine for treating rheumatoid arthritis
06/19/2012US8202847 Mutant human CD80 and compositions for and methods of making and using the same
06/19/2012US8202845 Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
06/19/2012CA2684169C Smac mimetic dimers and trimers useful as anti-cancer agents
06/19/2012CA2559302C 6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors
06/19/2012CA2478012C Internalizing anti-cd74 antibodies and methods of use
06/19/2012CA2398432C Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
06/19/2012CA2393975C Insect poison allergens with reduced ige reactivity and method for producing the same
06/19/2012CA2390898C Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
06/19/2012CA2349202C Method of preparing stable suspensions of insoluble microparticles
06/14/2012WO2012079022A1 Substituted dioxopiperidinyl phthalimide derivatives
06/14/2012WO2012078805A1 Polycyclic lpa1 antagonist and uses thereof
06/14/2012WO2012078504A1 TREATMENT OF CHRONIC INFLAMMATION WITH A 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVE
06/14/2012WO2012078210A1 Crth2 modulators and preparation thereof
06/14/2012WO2012077811A1 Galectin 9-secreting cell, production method for same, and application for same
06/14/2012WO2012077774A1 Device for prophylaxis and treatment of systemic lupus erythematosus
06/14/2012WO2012077133A1 Processes for preparation of montelukast sodium and purification of diol intermediate
06/14/2012WO2012077076A1 Treating or preventing sensitivity to milk allergens
06/14/2012WO2012076824A1 Novel derivatives of oxazaphosphorines that are pre-activated, use and method of preparation
06/14/2012WO2012076739A1 Bifidobacterium cect 7765 and use thereof in the prevention and/or treatment of excess weight, obesity and related pathologies
06/14/2012WO2012076429A1 Treating conditions associated with increased eotaxin with 25-hydroxyvitamin d3
06/14/2012WO2012076322A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/14/2012WO2012076321A1 Oligosaccharide composition for treating skin diseases
1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 1172